{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T15:27:44Z","timestamp":1775489264457,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,6]]},"DOI":"10.7759\/cureus.106524","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:13:51Z","timestamp":1775484831000},"source":"Crossref","is-referenced-by-count":0,"title":["Influenza A: Associated Severe Cholestatic Liver Injury in a Patient With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)"],"prefix":"10.7759","author":[{"given":"Aryan","family":"Neupane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashmita","family":"Chhetri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashima","family":"Ghimire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Gohar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5114\/ceh.2025.151800","article-title":"Hepatic involvement in major respiratory viral infections","volume":"11","author":"Rzymski P","year":"2025","unstructured":"Rzymski P, Dobrowolska K, Brzd\u0119k M, et al.. Hepatic involvement in major respiratory viral infections. Clin Exp Hepatol. 2025, 11:121-8. 10.5114\/ceh.2025.151800","journal-title":"Clin Exp Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0314970","article-title":"Oseltamivir-induced hepatotoxicity: A retrospective analysis of the FDA adverse event reporting system","volume":"20","author":"Yu L","year":"2025","unstructured":"Yu L, Xiang Q, Liu L. Oseltamivir-induced hepatotoxicity: A retrospective analysis of the FDA adverse event reporting system. PLoS One. 2025, 20:e0314970. 10.1371\/journal.pone.0314970","journal-title":"PLoS One"},{"key":"ref3","article-title":"First case of acute cholestatic hepatitis attributed to oseltamivir in a young girl with ah1n1 influenza","volume":"33","author":"Mastroianni A","year":"2021","unstructured":"Mastroianni A, Greco S, Vangeli V, et al.. First case of acute cholestatic hepatitis attributed to oseltamivir in a young girl with ah1n1 influenza. Ann Ig. 2021, 33:205-8.","journal-title":"Ann Ig"},{"key":"ref4","article-title":"","author":"Snyder E","unstructured":"Snyder E, Kashyap S, Lopez P. Hepatobiliary Iminodiacetic Acid Scan. StatPearls, Treasure Island (FL); https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539781\/."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001259","article-title":"ACG clinical guideline: diagnosis and management of idiosyncratic drug-induced liver injury","volume":"116","author":"Chalasani NP","year":"2021","unstructured":"Chalasani NP, Maddur H, Russo MW, et al.. ACG clinical guideline: diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2021, 116:878-98. 10.14309\/ajg.0000000000001259","journal-title":"Am J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner DE","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, et al.. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005, 41:1313-21. 10.1002\/hep.20701","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"158","author":"Taylor RS","year":"2020","unstructured":"Taylor RS, Taylor RJ, Bayliss S, et al.. Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Gastroenterology. 2020, 158:1611-1625.e12. 10.1053\/j.gastro.2020.01.043","journal-title":"Gastroenterology"},{"key":"ref8","article-title":"Primary Biliary Cholangitis","author":"Pandit S","year":"2023","unstructured":"Pandit S, Samant H. Primary Biliary Cholangitis. StatPearls, Treasure Island (FL); 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459209\/."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.12771","article-title":"Pathophysiology of sepsis-induced cholestasis: a review","volume":"6","author":"Ghenu MI","year":"2022","unstructured":"Ghenu MI, Drago\u015f D, Manea MM, et al.. Pathophysiology of sepsis-induced cholestasis: a review. JGH Open. 2022, 6:378-87. 10.1002\/jgh3.12771","journal-title":"JGH Open"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.1999.01982.x","article-title":"Inflammation-induced cholestasis","volume":"14","author":"Trauner M","year":"1999","unstructured":"Trauner M, Fickert P, Stauber RE. Inflammation-induced cholestasis. J Gastroenterol Hepatol. 1999, 14:946-59. 10.1046\/j.1440-1746.1999.01982.x","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/476000-influenza-a-associated-severe-cholestatic-liver-injury-in-a-patient-with-metabolic-dysfunction-associated-steatotic-liver-disease-masld","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:13:51Z","timestamp":1775484831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/476000-influenza-a-associated-severe-cholestatic-liver-injury-in-a-patient-with-metabolic-dysfunction-associated-steatotic-liver-disease-masld"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.106524","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,6]]}}}